Health Care
股价
$228.76
+0.38%市值
$25.12B
今日最高
$233.21
今日最低
$223.42
Quest Diagnostics delivered 10.2% revenue growth and 13.5% net-income growth in Q2 FY2026, led by higher Diagnostic Information Services testing volume, although lower revenue per requisition and higher service costs reduced operating margin to 15.1%.
关键风险:Profitability is sensitive to cost growth
Cost of revenue increased 10.9% year over year to $2.016B, exceeding the 10.2% increase in revenue to $3.043B. This contributed to operating margin declining to 15.1% from 15.9%, indicating that continued cost growth could constrain operating-profit expansion.
同属 Health Care Services 行业的其他公司